Literature DB >> 16946577

Salazosulfapyridine-induced encephalopathy with symmetrical lesions in the basal ganglia and thalami.

Hirokatsu Takahashi1, Shoichi Ito, Kiyomi Nagumo, Shigeyuki Kojima, Takeshi Umibe, Takamichi Hattori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16946577     DOI： 10.2169/internalmedicine.45.1666

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  2 in total

1.  Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults.

Authors:  Pierre A Robe; Didier H Martin; Minh T Nguyen-Khac; Maria Artesi; Manuel Deprez; Adelin Albert; Sophie Vanbelle; Stephane Califice; Markus Bredel; Vincent Bours
Journal:  BMC Cancer       Date:  2009-10-19       Impact factor: 4.430

2.  Central-Variant Posterior Reversible Encephalopathy due to Sulfasalazine: A Case Report.

Authors:  Levent Ocek; Ufuk Sener; Burcu S Demirtas; Metin M Ozcelik; Ozgur Oztekin; Yasar Zorlu
Journal:  Med Princ Pract       Date:  2015-08-21       Impact factor: 1.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.